[HTML][HTML] Targeting radioresistant breast cancer cells by single agent CHK1 inhibitor via enhancing replication stress
Y Zhang, J Lai, Z Du, J Gao, S Yang, S Gorityala… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Radiotherapy (RT) remains a standard therapeutic modality for breast cancer patients.
However, intrinsic or acquired resistance limits the efficacy of RT. Here, we demonstrate that …
However, intrinsic or acquired resistance limits the efficacy of RT. Here, we demonstrate that …
Targeting Radioresistant Breast Cancer Cells by Single Agent CHK1 Inhibitor via Enhancing Replication Stress
Y Zhang, J Lai, Z Du, J Gao, S Yang… - …, 2016 - engagedscholarship.csuohio.edu
Radiotherapy (RT) remains a standard therapeutic modality for breast cancer patients.
However, intrinsic or acquired resistance limits the efficacy of RT. Here, we demonstrate that …
However, intrinsic or acquired resistance limits the efficacy of RT. Here, we demonstrate that …
[HTML][HTML] Targeting radioresistant breast cancer cells by single agent CHK1 inhibitor via enhancing replication stress
Y Zhang, J Lai, Z Du, J Gao, S Yang, S Gorityala… - Oncotarget, 2016 - oncotarget.com
Targeting radioresistant breast cancer cells by single agent CHK1 inhibitor via enhancing
replication stress | Oncotarget Online ISSN: 1949-2553 Search: Oncotarget Home Editorial Board …
replication stress | Oncotarget Online ISSN: 1949-2553 Search: Oncotarget Home Editorial Board …
[PDF][PDF] Targeting Radioresistant Breast Cancer Cells by Single Agent CHK1 Inhibitor via Enhancing Replication Stress
Y Zhang, J Lai, Z Du, J Gao, S Yang - core.ac.uk
Radiotherapy (RT) remains a standard therapeutic modality for breast cancer patients.
However, intrinsic or acquired resistance limits the efficacy of RT. Here, we demonstrate that …
However, intrinsic or acquired resistance limits the efficacy of RT. Here, we demonstrate that …
Targeting radioresistant breast cancer cells by single agent CHK1 inhibitor via enhancing replication stress
Y Zhang, J Lai, Z Du, J Gao, S Yang… - …, 2016 - augusta.elsevierpure.com
Radiotherapy (RT) remains a standard therapeutic modality for breast cancer patients.
However, intrinsic or acquired resistance limits the efficacy of RT. Here, we demonstrate that …
However, intrinsic or acquired resistance limits the efficacy of RT. Here, we demonstrate that …
[PDF][PDF] Targeting radioresistant breast cancer cells by single agent CHK1 inhibitor via enhancing replication stress
Y Zhang, J Lai, Z Du, J Gao, S Yang, S Gorityala… - researchgate.net
Radiotherapy (RT) remains a standard therapeutic modality for breast cancer patients.
However, intrinsic or acquired resistance limits the efficacy of RT. Here, we demonstrate that …
However, intrinsic or acquired resistance limits the efficacy of RT. Here, we demonstrate that …
[PDF][PDF] Targeting Radioresistant Breast Cancer Cells by Single Agent CHK1 Inhibitor via Enhancing Replication Stress
Y Zhang, J Lai, Z Du, J Gao, S Yang - pdfs.semanticscholar.org
Radiotherapy (RT) remains a standard therapeutic modality for breast cancer patients.
However, intrinsic or acquired resistance limits the efficacy of RT. Here, we demonstrate that …
However, intrinsic or acquired resistance limits the efficacy of RT. Here, we demonstrate that …
Targeting radioresistant breast cancer cells by single agent CHK1 inhibitor via enhancing replication stress
Y Zhang, J Lai, Z Du, J Gao, S Yang… - …, 2016 - ohiostate.elsevierpure.com
Radiotherapy (RT) remains a standard therapeutic modality for breast cancer patients.
However, intrinsic or acquired resistance limits the efficacy of RT. Here, we demonstrate that …
However, intrinsic or acquired resistance limits the efficacy of RT. Here, we demonstrate that …
Targeting radioresistant breast cancer cells by single agent CHK1 inhibitor via enhancing replication stress
Y Zhang, J Lai, Z Du, J Gao, S Yang… - …, 2016 - pubmed.ncbi.nlm.nih.gov
Radiotherapy (RT) remains a standard therapeutic modality for breast cancer patients.
However, intrinsic or acquired resistance limits the efficacy of RT. Here, we demonstrate that …
However, intrinsic or acquired resistance limits the efficacy of RT. Here, we demonstrate that …
Targeting radioresistant breast cancer cells by single agent CHK1 inhibitor via enhancing replication stress.
Y Zhang, J Lai, Z Du, J Gao, S Yang, S Gorityala… - Oncotarget, 2016 - europepmc.org
Radiotherapy (RT) remains a standard therapeutic modality for breast cancer patients.
However, intrinsic or acquired resistance limits the efficacy of RT. Here, we demonstrate that …
However, intrinsic or acquired resistance limits the efficacy of RT. Here, we demonstrate that …